Printer Friendly

FDA approves room-temperature Betaseron. (News).

On January 15, 2002, the Food and Drug Administration (FDA) approved a form of Betaseron (interferon beta1 b) that can be kept at room temperature. Avonex and Rebif (both interferon beta-1a) should be refrigerated, but can be stored at 77[degrees] Fahrenheit for up to 30 days. Copaxone (glatiramer acetate) also requires refrigeration, but can be stored at up to 86[degrees] Fahrenheit for one week.

"The new room-temperature formulation provides greater convenience for both people with MS and pharmacies, allowing many more options when traveling and for storage," said Ralph Makar, Vice President of Marketing at Berlex Laboratories.

Room-temperature Betaseron is available now. For more information, call MS Pathways at: 800-788-1467.
COPYRIGHT 2002 National Multiple Sclerosis Society
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Inside MS
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 22, 2002
Words:112
Previous Article:Cleveland clinic zeroes in on factors that block natural myelin repair. (News).
Next Article:Society brings MS-related issues to Capitol Hill. (National MS Society News).
Topics:


Related Articles
Betaseron near formal approval.
About Betaseron ....
Betaseron update.
Treatment options - now there are three.
Betaseron for secondary-progressive MS?
Rebif trial disappointing for secondary-progressive MS.
Trial of Betaseron for progressive MS has mixed results.
New devices may ease use of Copaxone and Betaseron.
FDA approves Rebif. (News).
Rebif [in context].

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters